VivoSim Labs, Inc. Cash and Cash Equivalents
VivoSim Labs, Inc. (VIVS) had Cash and Cash Equivalents of $1.67 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $1.67M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $5.02M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.29M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $6.68M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $1.67M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $5.02M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $4.29M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $6.68M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $9.05M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $11.31M 10-K · filed 2026-07-14 | |
| 2024-12-31 | $1.16M 10-Q · filed 2026-02-11 | |
| 2024-09-30 | $3.17M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $6.19M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $2.90M 10-K · filed 2025-06-05 | |
| 2023-12-31 | $5.29M 10-Q · filed 2025-02-19 | |
| 2023-09-30 | $7.62M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $10.75M 10-Q · filed 2024-08-05 | |
| 2023-03-31 | $15.30M 10-K · filed 2024-05-31 | |
| 2022-12-31 | $20.20M 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $13.27M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $15.57M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $28.68M 10-K · filed 2023-07-14 | |
| 2021-12-31 | $30.27M 10-Q · filed 2023-02-09 | |
| 2021-09-30 | $33.79M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $36.01M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $37.36M 10-K · filed 2022-06-10 | |
| 2020-12-31 | $18.84M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $17.66M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $24.79M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $27.36M 10-K · filed 2021-06-15 | |
| 2019-12-31 | $30.47M 10-Q · filed 2021-02-08 | |
| 2019-09-30 | $30.35M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $35.49M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $36.48M 10-K · filed 2020-05-28 | |
| 2018-12-31 | $35.22M 10-Q · filed 2020-02-10 | |
| 2018-09-30 | $37.35M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $39.61M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $43.73M 10-K · filed 2019-06-03 | |
| 2017-12-31 | $47.34M 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $50.73M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $54.97M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $62.75M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $70.00M 10-Q · filed 2018-02-08 | |
| 2016-09-30 | $51.72M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $53.54M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $62.09M 10-K · filed 2018-05-31 | |
| 2015-12-31 | $70.03M 10-Q · filed 2017-02-09 | |
| 2015-09-30 | $76.86M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $86.00M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $50.14M 10-K · filed 2018-05-31 | |
| 2014-12-31 | $50.03M 10-Q · filed 2016-02-08 | |
| 2014-09-30 | $54.39M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $44.90M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $48.17M 10-K · filed 2017-06-07 | |
| 2013-12-31 | $49.82M 10-Q · filed 2015-02-06 | |
| 2013-09-30 | $53.36M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $12.85M 10-Q · filed 2014-08-08 | |
| 2013-03-31 | $15.63M 10-K · filed 2016-06-09 | |
| 2012-12-31 | $14.82M 10-K · filed 2015-06-09 | |
| 2012-09-30 | $7.68M 10-Q · filed 2013-11-08 | $7.68M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $8.47M 10-Q · filed 2013-08-09 | $8.47M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $10.35M 10-K · filed 2015-06-09 | $10.35M 10-Q · filed 2012-05-15 |
| 2012-03-16 | $10.35M 10-Q · filed 2013-11-08 | |
| 2011-12-31 | $340.00K 10-K · filed 2015-06-09 | $753.00 10-Q · filed 2012-01-17 |
| 2011-09-30 | $56.47K 10-Q · filed 2012-11-14 | $1.13K 10-Q · filed 2011-10-31 |
| 2011-06-30 | $18.96K 10-Q · filed 2012-08-14 | $1.77K 10-Q · filed 2011-10-31 |
| 2011-03-31 | $107.64K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $285.00K 10-K · filed 2014-06-10 | $62.51K 10-Q · filed 2012-01-17 |
| 2010-09-30 | $88.97K 10-Q · filed 2011-10-31 | |
| 2010-06-30 | $141.13K 10-Q · filed 2012-01-17 | |
| 2009-12-31 | $141.00K 10-KT · filed 2013-05-24 | |
| 2009-12-15 | $0.00 10-Q · filed 2012-01-17 | |
| 2009-12-14 | $0.00 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |